Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group (Q71693371)
Jump to navigation
Jump to search
scientific article published on 01 September 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group |
scientific article published on 01 September 1996 |
Statements
Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group (English)
Katlama C
Mouthon B
Gourdon D
Lapierre D
1 September 1996